Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases
Articles > Article · 2014
Authors: Oğuz Reşat SİPAHİ, Hasip KAHRAMAN, Sinan MERMER, Hüsnü PULLUKÇU, Meltem TAŞBAKAN, Bilgin ARDA, Tansu YAMAZHAN, Taşkın YURTSEVEN, Sohret AYDEMIR, Sercan ULUSOY
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, Journal Indexed in SCI Expanded, International, 2014, vol 23, pp 16-19
DOI: 10.1016/j.ijid.2014.01.027
Summary
Background: Tigecycline is a relatively new glycylcycline antimicrobial, active in vitro against a variety of Gram-positive and Gram-negative organisms. In this study we evaluated the outcomes of spondylodiscitis cases treated with tigecycline-including therapies retrospectively.